Risk Factors Associated With Tuberculosis Infection Among Household Contacts of Patients With Microbiologically Confirmed Pulmonary Tuberculosis in 3 High Tuberculosis Burden Countries
The Journal of Infectious Diseases · 15.09.2025 · 232 (3) · e448-e458
DOI: 10.1093/infdis/jiaf320 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 17.06.2025. Verfasst von Thobani Ntshiqa und 20 weiteren Autor:innen. Beteiligte Einrichtung: The Aurum Institute, Implementation Research Division, Johannesburg, South Africa. Hauptthemen laut MEDLINE: Tuberculosis, Pulmonary. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union.
Abstract (Originalsprache)
Background
Although tuberculosis preventive therapy guidelines support testing for tuberculosis infection in household contacts (HHCs), this adds operational complexity and cost and has often been abandoned. To understand utility of testing, we determined prevalence and risk factors for tuberculosis infection and tuberculosis preventive therapy eligibility among HHCs.
Methods
In a cross-sectional study conducted from July 2021 to September 2022 in Lesotho, South Africa, and Tanzania, we enrolled people with microbiologically confirmed pulmonary tuberculosis and their HHCs. HHCs were screened and tested for tuberculosis and tuberculosis infection using Xpert Ultra and QuantiFERON-TB-Gold-Plus, respectively. Generalized linear modelling was used to determine factors associated with tuberculosis infection, using robust standard errors. Tuberculosis preventive therapy eligibility was determined using World Health Organization criteria.
Results
We enrolled 342 people with pulmonary tuberculosis and 964 HHCs: 61.9% (597/964) were female with a median age of 18 years (interquartile range, 8–39 years). Overall, tuberculosis prevalence was 3.4% (25/739; 95% confidence interval [CI], 2.2%–4.9%), while tuberculosis infection prevalence was 48.7% (348/714; 95% CI, 45.0%–52.5%). Having tuberculosis infection increased with age per year (adjusted odds ratio [aOR], 1.02; 95% CI, 1.01–1.03), being from Lesotho (aOR, 1.82; 95% CI, 1.04–3.20), previous tuberculosis history (aOR, 2.25; 95% CI, 1.05–4.79), and being HIV negative (aOR, 2.30; 95% CI, 1.31–4.04). Overall, 62.2% (518/833; 95% CI, 58.8%–65.5%) were eligible for tuberculosis preventive therapy.
Conclusions
Almost half of tuberculosis-exposed HHCs aged ≥5 years had tuberculosis infection. Approximately two-thirds of HHCs were eligible for tuberculosis preventive therapy, implying that providing tuberculosis preventive therapy without prior testing for tuberculosis infection may be warranted in this population. Further work on cost-effectiveness is warranted when new tests become available. Clinical Trials Registration ISRCTN10003903.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Aurum Institute, Implementation Research Division, Johannesburg, South Africa.
- School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
- Institute for Global Health, University College London, London, United Kingdom.
- Jhpiego, Global Health Security, Baltimore, Maryland, USA.
- Mbeya Medical Research Centre, National Institute for Medical Research, Mbeya, Tanzania.
- Monitoring, Evaluation and Research Division, Jhpiego, Maseru, Lesotho.
ORCID-Profile: Thobani Ntshiqa, Jeniffer Nagudi, Yohhei Hamada, Andrew Copas, Stacie Stender, Issa Sabi, Elias Nyanda Ntinginya, Julieth Lalashowi, Manthomeng Matete, Don Mudzengi, Lilian Tina Minja, Tobias Chirwa, Knut Lönnroth, Viola Dreyer, Molebogeng Rangaka, Salome Charalambous, Kavindhran Velen
Förderung
- European Union
Zitieren
APA
Ntshiqa, T., Nagudi, J., Hamada, Y., Copas, A., Stender, S., Sabi, I., Ntinginya, E. N., Lalashowi, J., Matete, M., Ntshamane, K., Morojele, I., Ngobeni, M., Mudzengi, D., Minja, L. T., Chirwa, T., Lönnroth, K., Dreyer, V., Niemann, S., Rangaka, M., …, & Velen, K. (2025). Risk Factors Associated With Tuberculosis Infection Among Household Contacts of Patients With Microbiologically Confirmed Pulmonary Tuberculosis in 3 High Tuberculosis Burden Countries. The Journal of Infectious Diseases, 232(3), e448-e458. https://doi.org/10.1093/infdis/jiaf320
Vancouver
Ntshiqa T, Nagudi J, Hamada Y, Copas A, Stender S, Sabi I, et al. Risk Factors Associated With Tuberculosis Infection Among Household Contacts of Patients With Microbiologically Confirmed Pulmonary Tuberculosis in 3 High Tuberculosis Burden Countries. The Journal of Infectious Diseases. 2025;232(3):e448-e458. doi:10.1093/infdis/jiaf320
BibTeX
@article{Ntshiqa2025,
author = {Ntshiqa, Thobani and Nagudi, Jeniffer and Hamada, Yohhei and Copas, Andrew and Stender, Stacie and Sabi, Issa and Ntinginya, Elias Nyanda and Lalashowi, Julieth and Matete, Manthomeng and Ntshamane, Keolebogile and Morojele, Ithabeleng and Ngobeni, Miyelani and Mudzengi, Don and Minja, Lilian Tina and Chirwa, Tobias and Lönnroth, Knut and Dreyer, Viola and Niemann, Stefan and Rangaka, Molebogeng and Charalambous, Salome and Velen, Kavindhran},
title = {Risk Factors Associated With Tuberculosis Infection Among Household Contacts of Patients With Microbiologically Confirmed Pulmonary Tuberculosis in 3 High Tuberculosis Burden Countries},
journal = {The Journal of Infectious Diseases},
year = {2025},
volume = {232},
number = {3},
pages = {e448--e458},
doi = {10.1093/infdis/jiaf320}
}
EUVIMED